MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-20-0023888
Presinus Pharmaceuticals Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.88 Lakh
▼ 24% YoY
Net loss · FY 2025
₹5.63 Lakh
Net margin -18.9%
EBITDA · FY 2025
-₹5.63 Lakh
EBITDA margin -18.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Presinus Pharmaceuticals Private Limited
Data last updated:
Presinus Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74999MH2016PTC284588. Its GSTIN is 27AAICP7825P1ZL (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jayesh Deepak Kukreja and Girish Damodar Kalamkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 27 Sachitanand Nagar, Nagpur, Maharashtra, India – 440024.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.88 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net loss of ₹5.63 Lakh (net margin -18.9%) and EBITDA of -₹5.63 Lakh (EBITDA margin -18.9%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
Presinus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0023888). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website presinus.com.
Company details
CIN U74999MH2016PTC284588
Registration Number 284588
Incorporation Date 09 August 2016
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0023888
Key People
Jayesh Deepak Kukreja Director Girish Damodar Kalamkar Director Deepak Arjundas Kukreja Director Recognitions & Rankings of Presinus Pharmaceuticals
Contact details
Presinus Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is presinus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 27 Sachitanand Nagar, Nagpur, Maharashtra, India – 440024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Presinus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Presinus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Presinus Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Presinus Pharmaceuticals Private Limited, buy the company report.
Financials of Presinus Pharmaceuticals Private Limited
FY 2025 filings availablePresinus Pharmaceuticals Private Limited reported revenue of ₹29.88 Lakh (down 24% YoY) for FY 2025.
Revenue · FY 2025
₹29.88 Lakh ▼ 24%
Net loss · FY 2025
₹5.63 Lakh margin -18.9%
EBITDA · FY 2025
-₹5.63 Lakh margin -18.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 138%
3 years · compounded
▼ 299%
Revenue has declined at a compounded annual rate (CAGR) of 4% over three years, including a 24% fall in the latest year. EBITDA fell 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18.9% | ||||
| Net Profit Margin | -18.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Presinus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Presinus Pharmaceuticals Private Limited
Presinus Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayesh Deepak Kukreja Also directs: Zaneka Healthcare Limited, Navigator Endowings (I) Private Limited | Director | 05 Apr 2025 | 1 Years 6 Months | Current |
| Girish Damodar Kalamkar Also directs: Promarc Pharmaceuticals Private Limited, Promarc Medicose Private Limited, Equitas Pharmaceuticals Limited and 3 more | Director | 09 Aug 2016 | 10 Years 2 Months | Current |
| Deepak Arjundas Kukreja | Director | 05 Apr 2025 | 1 Years 6 Months | Current |
| Mayuresh Dilip Katyayan Also directs: Promarc Cosmetics Private Limited, Promarc Pharmaceuticals Private Limited, Promarc Medicose Private Limited and 5 more | Director | 09 Aug 2016 | 10 Years 2 Months | Current |
Auditor
Presinus Pharmaceuticals Private Limited is audited by G. P. DEODHAR & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G. P. DEODHAR & CO. | FY 2024 | 102264W |
Shareholding
The shareholding of Presinus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Presinus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Presinus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Presinus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Presinus Pharmaceuticals Private Limited has 1 active EPFO establishment as of Oct 09, 2025.
Active EPFO establishments
1
GST
Presinus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICP7825P1ZL | Maharashtra | Active | 11 Sep 2017 |
To see the full GST registrations and return filing status of Presinus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Presinus Pharmaceuticals Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Deepak Arjundas Kukreja was appointed as Director on 05 Apr 2025.
AGM
Presinus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Deepak Arjundas Kukreja was appointed as Director.
Appointed
Jayesh Deepak Kukreja was appointed as Director.
Filing
Presinus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Girish Damodar Kalamkar was appointed as Director.
Appointed
Mayuresh Dilip Katyayan was appointed as Director.
Incorporation
09 Aug 2016
Presinus Pharmaceuticals Private Limited was registered on 09 Aug 2016 with Roc Nagpur & aged 10 years 2 months as per MCA records.
Frequently asked questions
Presinus Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 August 2016 (10+ years old) and is registered under CIN U74999MH2016PTC284588.
Presinus Pharmaceuticals has 4 current directors:
- Jayesh Deepak Kukreja - Director
- Girish Damodar Kalamkar - Director
- Deepak Arjundas Kukreja - Director
- Mayuresh Dilip Katyayan - Director
The latest financial statements of Presinus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Presinus Pharmaceuticals is 27AAICP7825P1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Presinus Pharmaceuticals is U74999MH2016PTC284588. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Presinus Pharmaceuticals was incorporated on 09 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.
Deepak Arjundas Kukreja was appointed as Director on 05 Apr 2025. Jayesh Deepak Kukreja was appointed as Director on 05 Apr 2025. Girish Damodar Kalamkar was appointed as Director on 09 Aug 2016. Presinus Pharmaceuticals has 4 board changes on record in total.
Yes, Presinus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0023888).
Presinus Pharmaceuticals can be reached through the website presinus.com. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Presinus Pharmaceuticals is at Plot No. 27 Sachitanand Nagar, Nagpur, Maharashtra, India – 440024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages